AI assistant
Vitrolife — Director's Dealing 2021
Dec 7, 2021
2989_iss_2021-12-07_ac114537-4af3-4051-8473-7bf0b0d21a8d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Press Release December 7, 2021 Gothenburg, Sweden
Vitrolife´s CEO sells a portion of his shareholding
Vitrolife's CEO Thomas Axelsson has today sold 38,300 shares worth SEK 18.7 million. The remaining number of shares amounts to 13,000 shares.
"The Vitrolife share has developed very positively since I acquired the shares in 2012 and I therefore choose to realize part of the profit for private financial reasons," says Thomas Axelsson, CEO of Vitrolife AB. The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.
Gothenburg, December 7, 2021 VITROLIFE AB (publ) Thomas Axelsson, CEO
Contact persons:
Thomas Axelsson, CEO, tel: +46 31 721 80 01 Mikael Engblom, CFO, tel: +46 31 721 80 14
_____________________________________________________________________________________________________
___________________________________________________________________________________________________________________________________
Vitrolife AB (publ), Box 9080, SE-400 92 Gothenburg. Corporate ID number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 99. E-mail: [email protected]. Website: www.vitrolife.com
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 10.50 am CET on December 7, 2021.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.